←Back to list

Modern Health

Operator of a mental wellness platform intended to help companies manage their employee's health benefits.
Operator of a mental wellness platform intended to help companies manage their employee's health benefits.
Other Healthcare Services 📍 San Francisco, CA Founded 2017
Current Valuation
$1.2B
as of 2021-Q1
UNICORN

QL Price

$849.2M
-27% vs last round
QuantLogix's current estimate for Modern Health, published 2026-09-27 — below the last disclosed round of $1.2B (2025-10).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round $1.2B 2025-10 weight 0.5
Secondary market print $568.62M 2026-06-27 weight 0.58
How this price has held up
No round has priced for Modern Health since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
How to actually get exposure to Modern Health →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Modern Health, 2026-09-27 (e04c7db2bfc2a932). The id pins this exact claim, so a citation stays checkable after the price moves. Model estimate for research — not a quote, target price, or investment advice.

IPO Outlookprivate

Is Modern Health going public?
No. Modern Health is private and has not filed to go public. There is no S-1 on file.
What is Modern Health's valuation in 2026?
Modern Health is valued at $1.2B as of 2021-Q1, set by its Series D ($74M, Feb 2021). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Modern Health filed an S-1?
No public S-1 is on file for Modern Health.
How much has Modern Health raised?
Modern Health has raised $170.07M in total, most recently a Series D of $74M in Feb 2021.
Is Modern Health publicly traded — can you buy Modern Health stock?
No. Modern Health is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Modern Health on its Pre-IPO Access Desk.
How to actually get exposure to Modern Health →
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.

Company Profile

Founded
2017
HQ
San Francisco, CA
Employees
350
Total Raised
$170.07M
Last Round
Series D — $74M (Feb 2021)
IPO Status
private

Fundraising Status

Series D · $74M · 5y 7mo ago
privateTotal raised $170.07M

Secondary Market

Implied price / share
$21.4
Last round price / share
$44
vs last round
-51.4%
Last round price vs secondary price
Last round vs current secondary price per share$44.00Last round$21.40Current
Secondary price return by period
Secondary market period returns3-month+4.5%6-month-0.4%1-year+0.5%All-time-51.4%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series D$74MFeb 2021—$1.2B

Vertical Intelligence — Biotech / Gene Therapy

No name-verified sponsor record on ClinicalTrials.gov for Modern Health — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-27. Re-checked weekly.

Talent Signal

Hiring trend
▼ Hiring downtrend
-32% vs 2026-08
Open roles
13
via greenhouse
Product-build share
31%
engineering, research, product, design
Trajectory
tightening
balanced build + GTM — 31% builders vs 69% go-to-market/G&A — scaling both sides.
Open roles trending down; no tracked executive churn.
Open roles by month
Open roles by month19Aug '2613Sep '26
Open roles by function
Open roles by functionOther6Product2Research1Marketing1Sales & GTM1Engineering1Ops & People1
■ product-building   ■ go-to-market / G&A
Associate Principal - Outcomes ResearcherProgram Manager, Business & Partnership ProgramsProgram Manager, Product OperationsStaff Software Engineer: Growth Engineering Director of Product Marketing Don’t see what you’re looking for?
Counted from Modern Health's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareTherapeuticsWellnessmHealth
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q1. Refreshed quarterly.